GOULD ROBERT J (See Remarks) sold 3.0% of their position (15K shares) of FULCRUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $165.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/21/2025ACC: 0001193125-25-291392
DirectorOfficer10% Owner· See Remarks
Since Jul 2019
-15K
Net shares
Net seller
$165.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15K
Price / share
$11.03
Trade value
$165.50K
% of position
3.0%
11/19/2025
499.86K→484.86K
Total
Net shares
−15K
Net value
-$165.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/19/2025 | S · Sale | −15K | $11.03 | $165.50K | 3.0% | 499.86K | 484.86K |
| Total | −15K | -$165.50K | ||||||
Derivative Transactions0
No derivative transactions reported